Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Comparative trial of low- and high-dose zonisamide as monotherapy for childhood epilepsy.

Eun SH, Kim HD, Eun BL, Lee IK, Chung HJ, Kim JS, Kang HC, Lee YM, Suh ES, Kim DW, Eom S, Lee JS, Moon HK.

Seizure. 2011 Sep;20(7):558-63. doi: 10.1016/j.seizure.2011.04.005. Epub 2011 May 4.

2.

Efficacy and tolerability of zonisamide versus controlled-release carbamazepine for newly diagnosed partial epilepsy: a phase 3, randomised, double-blind, non-inferiority trial.

Baulac M, Brodie MJ, Patten A, Segieth J, Giorgi L.

Lancet Neurol. 2012 Jul;11(7):579-88. doi: 10.1016/S1474-4422(12)70105-9. Epub 2012 Jun 8.

PMID:
22683226
3.

Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.

Trevathan E, Kerls SP, Hammer AE, Vuong A, Messenheimer JA.

Pediatrics. 2006 Aug;118(2):e371-8. Epub 2006 Jul 17.

PMID:
16847080
4.

Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy.

Shinnar S, Pellock JM, Conry JA.

Eur J Paediatr Neurol. 2009 Jan;13(1):3-9. doi: 10.1016/j.ejpn.2008.01.004. Epub 2008 Mar 14.

PMID:
18343174
5.
6.

Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy.

Kothare SV, Valencia I, Khurana DS, Hardison H, Melvin JJ, Legido A.

Epileptic Disord. 2004 Dec;6(4):267-70.

7.

Effects of zonisamide monotherapy in children with epilepsy.

Seki T, Kumagai N, Maezawa M.

Seizure. 2004 Dec;13 Suppl 1:S26-32; discussion S33.

8.

Zonisamide monotherapy for epilepsy in children and young adults.

Wilfong AA.

Pediatr Neurol. 2005 Feb;32(2):77-80.

PMID:
15664764
9.

Efficacy and tolerability of adjunctive therapy with zonisamide in childhood intractable epilepsy.

Lee YJ, Kang HC, Seo JH, Lee JS, Kim HD.

Brain Dev. 2010 Mar;32(3):208-12. doi: 10.1016/j.braindev.2009.02.003. Epub 2009 Mar 21.

PMID:
19304420
11.
12.

A prospective audit of adjunctive zonisamide in an everyday clinical setting.

Stephen LJ, Kelly K, Wilson EA, Parker P, Brodie MJ.

Epilepsy Behav. 2010 Apr;17(4):455-60. doi: 10.1016/j.yebeh.2010.01.016. Epub 2010 Mar 5.

PMID:
20207201
13.

Short-term efficacy and safety of zonisamide as adjunctive treatment for refractory partial seizures: a multicenter open-label single-arm trial in Korean patients.

Heo K, Lee BI, Yi SD, Cho YW, Shin DJ, Song HK, Kim OJ, Park SP, Kim SE, Kim SH, Lee JH, Kim KS, Lee SJ.

Seizure. 2012 Apr;21(3):188-93. doi: 10.1016/j.seizure.2011.12.005. Epub 2012 Jan 4.

14.

A randomized phase III trial of adjunctive zonisamide in pediatric patients with partial epilepsy.

Guerrini R, Rosati A, Segieth J, Pellacani S, Bradshaw K, Giorgi L.

Epilepsia. 2013 Aug;54(8):1473-80. doi: 10.1111/epi.12233. Epub 2013 Jul 9.

15.

Randomized, controlled clinical trial of zonisamide as adjunctive treatment for refractory partial seizures.

Sackellares JC, Ramsay RE, Wilder BJ, Browne TR 3rd, Shellenberger MK.

Epilepsia. 2004 Jun;45(6):610-7.

16.

Long-term cognitive and mood effects of zonisamide monotherapy in epilepsy patients.

Park SP, Hwang YH, Lee HW, Suh CK, Kwon SH, Lee BI.

Epilepsy Behav. 2008 Jan;12(1):102-8. Epub 2007 Oct 22.

PMID:
17945539
17.

Effectiveness and tolerability of zonisamide in children with epilepsy: a retrospective review.

Tan HJ, Martland TR, Appleton RE, Kneen R.

Seizure. 2010 Jan;19(1):31-5. doi: 10.1016/j.seizure.2009.10.008. Epub 2009 Nov 25.

18.

Management and monitoring of patients treated with zonisamide: the OZONE study.

Dupont S, Biraben A, Lavernhe G, Marquet T, Allaf B.

Epileptic Disord. 2013 Sep;15(3):278-88. doi: 10.1684/epd.2013.0591.

19.

Zonisamide in children and young adults with refractory epilepsy: an open label, multicenter Italian study.

Coppola G, Grosso S, Verrotti A, Parisi P, Luchetti A, Franzoni E, Mangano S, Pelliccia A, Operto FF, Iannetti P, Curatolo P, Balestri P, Pascotto A.

Epilepsy Res. 2009 Feb;83(2-3):112-6. doi: 10.1016/j.eplepsyres.2008.10.012. Epub 2008 Dec 10.

PMID:
19081227
20.

Efficacy, tolerability, and retention rates of zonisamide in older adult patients with focal-onset epilepsy: Experiences from two tertiary epilepsy centers.

Doğan EA, Genç E, Genç BO, Erdoğan Ç.

Epilepsy Behav. 2017 Nov;76:19-23. doi: 10.1016/j.yebeh.2017.08.040. Epub 2017 Sep 18.

PMID:
28927711

Supplemental Content

Support Center